Vitamin D3 differentially regulates parathyroid hormone/parathyroid hormone-related peptide receptor expression in bone and cartilage

Journal of Clinical Investigation

Volumn 103, Issue 3, 1999, Pages 373-381

  Amizuka, Norio ^a   Kwan, Mei Yee ^b   Goltzman, David ^b,c   Ozawa, Hidehiro ^a   White, John H ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b MCGILL UNIVERSITY   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL DERIVATIVE; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

ARTICLE; DOWN REGULATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSCRIPTION; HORMONAL REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; OSTEOBLAST; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0344450755     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3265     Document Type: Article

References (65)

1. Backsai, B.J., and Friedman, P.A. 1995. Activation of latent calcium channels in renal epithelial cells by parathyroid hormone. Nature. 347:388-391.
2. Muff, R., Fischer, J.A., Biber, J., and Murer, H. 1992. Parathyroid hormone receptors in control of proximal tubule function. Annu. Rev. Physiol. 54:67-79.
3. Wasserman, R.H., and Fullmer, C.S. 1983. Calcium transport proteins, calcium absorption and vitamin D. Annu. Rev. Physiol. 45:375-390.
4. DeLuca, H.F. 1985. Vitamin D-dependent calcium transport. Soc. Gen. Physiol. Ser. 39:159-176.
5. Hock, J.M., et al. 1986. Stimulation of undermineralized matrix formation by 1,25-dihydroxyvitamin D3 in longbones of rats. Calcif. Tissue Int. 38:79-86.
6. Naveh-Many, T., and Silver, J. 1990. Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J. Clin. Invest. 86:1313-1319.
7. Delmez, J.A., et al. 1989. Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J. Clin. Invest. 83:1349-1355.
8. Goltzman, D., and Hendy, G.N. 1995. Parathyroid hormone. In Principles and practice of endocrinology and metabolism. 2nd ed. K.L. Becker, editor. J.B. Lippincott, Philadelphia, PA. 455-467.
9. Burtis, W.J., et al. 1987. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J. Biol. Chem. 161:7151-7156.
10. Kemp, B.E., et al. 1987. Parathyroid hormone-related protein of malignancy: active synthetic fragments Science. 238:1568-1570.
11. Strewler, G., et al. 1987. Parathyroid hormonelike protein from human renal carcinoma cells: structural and functional homology with parathyroid hormone. J. Clin. Invest. 80:1803-1807.
12. Suva, L.J., et al. 1987. A parathyroid hormone-relaced protein implicated malignant hypercalcemia; cloning and expression. Science. 237:893-896.
13. Amizuka, N., Henderson, J.E., Warshawsky, H., Goltzman, D., and Karaplis, A.C. 1994. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J. Cell. Biol. 126:1611-1623.
14. Amizuka, N., et al. 1996. Haploinsufficiency of parathyroid hormone related peptide (PTHrP) results in abnormal post-natal bone development. Dev. Biol. 175:166-176.
15. Amizuka, N., et al. 1996. Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide (PTHrP) gene deletion. Endocrinology. 137:5055-5067.
16. Karaplis, A.C., et al. 1994. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev. 8:277-289.
17. Weir, E., et al. 1996. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodisplasia and delayed endochondral bone formation. Proc. Natl. Acad. Sci. USA. 93:10240-10245.
18. Moniz, C., et al. 1990. Parathyroid hormone related peptide in normal human fetal development. Mol. Endocrinol. 5:259-266.
19. Kaiser, S., et al. 1992. Enhanced growth of a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide. J. Biol. Chem. 267:13623-13628.
20. Kaiser, S., Sebag, M., Rhim, J.S., Kremer, R., and Goltzman, D. 1994. Antisense-mediated inhibition of parathyroid hormone-related peptide (PTHrP) production in a keratinocyte cell line impedes differentiation. Mol. Endocrinol. 8:139-147.
21. van de Stolpe, A., et al. 1993. Parathyroid hormone-related peptide as an endogenous inducer of parietal endoderm differentiation. J. Cell Biol. 120:235-243.
22. Jiang, B., et al. 1995. Role of parathyroid hormone-related protein in the proliferation of vascular smooth muscle cells. Miner. Electrolyte Metab. 21:157-160.
23. Garcia-Ocana, A., et al. 1995. Parathyroid hormone-related protein is an autocrine modulator of rabbit proximal tubule cell growth. J. Bone Miner. Res. 10:1875-1884.
24. Nichols, C.A., Metz, M.A., and Cline, W.H. Jr. 1986. Endothelium-independent linkage of parathyroid hormone receptors of rat vascular tissue with increased adenosine 3′5′-monophosphate and relaxation of vascular smooth muscle. Endocrinology. 119:349-356.
25. Nichols, G.A., Nichols, M.A., and Helwig, J.J. 1990. Binding of parathyroid hormone and parathyroid hormone-related peptide to vascular smooth muscle of rabbit renal microvessels. Endocrinology. 126:721-727.
26. Winquist, R.J., Baskin, E.P., and Vlasuk, G.P. 1987. Synthetic tumor-derived human hypercalcemic factor exhibits parathyroid hormone like vasal relaxation in renal arteries. Biochem. Biophys. Res. Commun. 149:227-232.
27. Hongo, T., et al. 1991. Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation. J. Clin. Invest. 6:1841-1847.
28. Rocacusachs, A., DiPette, D.J., and Nichols, G.A. 1991. Regional and synthetic effects of parathyroid hormone-related protein - preservation of cardiac function and coronary and renal flow with reduced blood pressure. J. Pharmacol. Exp. Ther. 256:110-118.
29. Senior, P.V., Heath, D.A., and Beck, F. 1990. Expression of parathyroid hormone-related protein mRNA in the rat before birth: demonstration by hybridization histochemistry. J. Mol. Endocrinol. 6:281-290.
30. Kramer, S., et al. 1991. Immunological identification and distribution of parathyroid hormone-like protein polypeptides in normal and malignant tissues. Endocrinology. 128:1927-1937.
31. Moseley, J.M., et al. 1991. Immunohistochemical detection of parathyroid hormone-related protein in human fetal epithelia. J. Clin. Endocrinol. Metab. 73:478-484.
32. Jüppner, et al. 1991. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science. 254:1024-1026.
33. Urena, P., et al. 1993. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology, 133:617-623.
34. McCuaig, K.A., Clarke J.C., and White, J.H. 1994. Molecular cloning of the gene encoding the mouse parathyroid hormone/parathyroid hormone-related peptide receptor. Proc. Natl. Acad. Sci. USA. 91:5051-5055.
35. McCuaig, K.A., et al. 1995. Parathyroid hormone/parathyroid hormone related peptide receptor gene transcripts are expressed from tissue-specific and ubiquitous promoters. Nucleic. Acids. Res. 23:1948-1955.
36. Amizuka, N., et al. 1997. Cell-specific expression of the parathyroid hormone(PTH)/PTH-related peptide receptor gene in rat kidney from kidney-specific and ubiquitous promoters. Endocrinology. 138:469-481.
37. Suda, N., et al. 1996. Expression of parathyroid hormone-related protein in cells of osteobtast lineage. J. Cell. Physiol. 166:94-104.
38. Tso, J.Y., Sun, X.H., Kao, T., Reece, K.S., and Wu, R. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenese cDNA: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
39. Ferrara, J., McCuaig, K., Hendy, G.N., Uskokovic, M., and White, J.H. 1994. Highly potent transcriptional activation by 16-ene derivatives of 1,25-dihydroxyvitamin D3: lack of modulation by 9-cis retinoic acid of response to 1,25-dihydroxyvitamin D3 or its derivatives. J. Biol. Chem. 269:2971-2981.
40. Miki, A., Tanaka, Y., Ogata, S., and Ikehara, Y. 1986. Selective preparation and characterization of membranous and soluble forms of alkaline phosphatase from rat tissues. A comparison with the serum enzyme. Eur. J. Biochem. 160:41-48.
41. Nordeen, S.K. 1988. Lucifcrase reporter gene vectors for analysis of promoters and enhancers. Biotechniques. 6:454-458.
42. Kothary, R., et al. 1989. Inducible expression of an hsp68-IacZ hybrid gene in transgenic mice. Development. 105:707-714.
43. Demay, M.B., Kiernan, M.S., DeLuca, H.F., and Kronenberg, H.M. 1992. Sequences in the human parathyroid hormone gene that bind the 1,25 dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25 dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA. 89:8097-8101.
44. Bernier, S.M. and Goltzman, D. 1993. Regulation of expression of the chondrocytic phenotype in a skeletal cell line (CFK2) in vitro. J. Bone Miner. Res. 8:475-483.
45. Rouleau, M.F., Warshawsky, H., and Goltzman, D. 1986. Parathyroid hormone binding in vivo renal, hepatic, and skeletal tissues of the rat using a radioautographic approach. Endocrinology. 118:919-931.
46. Rouleau, M.F., Mitchell, J., and Goltzman, D. 1988. In vivo distribution of parathyroid hormone receptors in bone: evidence that a predominant osseus target cell is not the mature osteoblast. Endocrinology. 123:187-191.
47. Rouleau, M.F., Mitchell, J., and Goltzman, D. 1990. Characterization of the major parathyroid hormone target cell in the endosteal metaphysis of rat long bones. J. Bone Miner. Res. 5:1043-1053.
48. Kremer, R., et al. 1996. Identification and characterization of 1,25-dihydroxyvitamin D3-responsive represser sequences in the rat parathyroid hormone-related peptide gene. J. Biol. Chem. 271:16310-16316.
49. Okazaki, T., Igarashi, T., and Kronenberg, H.M. 1988. 5́-flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3. J. Biol. Chem. 263:2203-2208.
50. Clemens, T.L. et al. 1988. Immuncytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. Endocrinology. 122:1224-1230.
51. Amizuka, N., and Ozawa, H. 1992. Intracellular localization and translocation of 1α,25(OH)2D3 receptor in osteoblasts. Arch. Histol. Cytol. 55:77-88.
52. Stumpf, W.E., et al. 1994. 1,25-Dihydroxyvitamin D3 and 22-oxa-1,25-dihydroxyvitamin D3 in vivo nuclear receptor binding in developing bone during endochondral and intramembranous ossification. Histochemistry. 102:183-194.
53. Kato, Y., et al. 1990. Role of 1,25-dihydroxycholecalciferol in growth-plate cartilage: inhibition of terminal differentiation of chondrocyres in vitro and in vivo. Proc. Natl. Acad. Sci. USA. 87:6522-6526.
54. Klaus, G., Meinhold-Heerlein, R., Milde, P., Ritz, E., and Mehls, O. 1991. Effect of vitamin D on growth cartilage cell proliferation in vitro. Pediatr. Nephrol. 5:461-466.
55. Schwartz, Z., et al. 1992. Production of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by growth zone and resting zone chondrocytes is dependent on cell maturation and is regulated by hormones and growth factors. Endocrinology. 130:2495-2504.
56. Takahashi, N., et al. 1988. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 122:1373-1382.
57. Suda, T., Takahashi, N., and Martin, T.J. 1992. Modulation of osteoclast differentiation. Endocr. Rev. 13:66-80.
58. McSheehy, P.M.J., and Chambers, T.J. 1986. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology. 119:1654-1659.
59. Akatsu, T., et al. 1989. Parathyroid hormone (PTH)-related protein is a potent stimulator of osteoclast-like multinucleated cell formation to the same extent as PTH in mouse marrow cultures. Endocrinology. 125:20-27.
60. Takahashi, N., et al. 1988. Osteoblastic cell are involved in osteoclast formation. Endocrinology. 123:2600-2602.
61. Udagawa, N., et al. 1989. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1805-1813.
62. McSheehy, P.M.J., and Chambers, T.J. 1987. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J. Clin. Invest. 80:425-429.
63. Xie, L.Y., Leung, A., Segre, G.V., Yamamoto, I., and Abou-Samra, A.-B. 1996. Down-regulation of the PTH/PTHrP receptor by vitamin D3 in the osteoblast-like ROS 17/2.8 cells. Am. J. Physiol. 270:E6S4-E660.
64. Mackey, S.L., Heymont, J.L., Kronenberg, H.M., and Demay, M.B. 1996. Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol. Endocrinol. 10:298-305.
65. Fraquharson, C., Rennie, J.S., Loveridge, N., and Whitehead, C.C. 1996. In vivo and in vitro effect of 1,25-dihydroxyvitamin D3 and 1,25-dihydroxy-16-ene-23yne-vitamin D3 on the proliferation and differentiation of avian chondrocytes: their role in tibial dyschondroplasia. J. Endocrinol. 148:465-474.